Literature DB >> 33180046

Papillary thyroid carcinoma in children with Hashimoto's thyroiditis - a review of the literature between 2000 and 2020.

Maria Lucia Sur1,2, Remus Gaga1,2, Călin Lazăr1,2, Cecilia Lazea1,2, Cornel Aldea1,2, Daniel Sur3,4.   

Abstract

Objectives Thyroid cancer is the most common pediatric endocrine neoplasm representing 3% of all malignancies in children. Hashimoto's thyroiditis (HT) is also a common disorder in the pediatric age range. Patients with HT frequently develop enlarged thyroid with nodules. We aimed to provide a literature review on the frequency of papillary thyroid carcinoma (PTC) in patients with HT. Content A literature search of the PubMed database between 2000 and 2020 was performed, using the relevant keywords "papillary thyroid carcinoma," "Hashimoto's thyroiditis" and "children". We followed the PRISMA statement guidelines during the preparation of this review. Six studies (n=2,065 patients with HT) were retained for the final analysis. The follow-up of the patients with HT was from 2 to 10 years. PTC was diagnosed in 0.67-7.87% of the HT patients included in these studies. In patients with HT and nodules, the percentage of PTC varied between 5.13 and 35%. The overall occurrence of PTC in patients with HT was 3.07%. Summary and Outlook The number of patients developing thyroid nodules in relation to HT was increased. The development of PTC in children with HT appeared to be higher than in the normal population.

Entities:  

Keywords:  Hashimoto’s thyroiditis; children; papillary thyroid carcinoma

Year:  2020        PMID: 33180046     DOI: 10.1515/jpem-2020-0383

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  1 in total

1.  Metastatic Papillary Thyroid Carcinoma in a Paediatric Patient.

Authors:  Nthabiseng Ellen Mothata; Takalani Gidion Morulana; Nyaweleni Tshifularo; Phumudzo Bridgett Nemutaduni; Nozipho Elizabeth Nyakale; Moshawa Calvin Khaba
Journal:  Case Rep Endocrinol       Date:  2021-01-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.